Scarica l'app Stockscreener
16.18
0.86%
-0.14
Dopo l'orario di chiusura:
16.18
Precedente Chiudi:
$16.32
Aprire:
$16.21
Volume 24 ore:
242.57K
Relative Volume:
0.94
Capitalizzazione di mercato:
$580.71M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-0.06%
1M Prestazione:
-12.26%
6M Prestazione:
-39.99%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$15.62
$16.25
Intervallo di 1 settimana:
$15.55
$16.70
Portata 52W:
$10.01
$32.75
Ceribell Inc Stock (CBLL) Company Profile
Nome
Ceribell Inc
Settore
Industria
Telefono
(800) 436-0826
Indirizzo
360 N. PASTORIA AVENUE, SUNNYVALE
Confronta CBLL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CBLL
Ceribell Inc
|
16.18 | 580.71M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
132.60 | 224.65B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
104.24 | 151.13B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
381.36 | 139.34B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.45 | 107.01B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
75.11 | 44.25B | 5.54B | 4.18B | 259.90M | 7.00 |
Ceribell Inc Stock (CBLL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-04 | Iniziato | Ladenburg Thalmann | Buy |
| 2024-11-05 | Iniziato | BofA Securities | Buy |
| 2024-11-05 | Iniziato | Canaccord Genuity | Buy |
| 2024-11-05 | Iniziato | JP Morgan | Overweight |
| 2024-11-05 | Iniziato | TD Cowen | Buy |
| 2024-11-05 | Iniziato | William Blair | Outperform |
Mostra tutto
Ceribell Inc Borsa (CBLL) Ultime notizie
Invesco Ltd. Takes $252,000 Position in CeriBell (NASDAQ:CBLL) - Defense World
Legal & General Group Plc Takes Position in CeriBell (NASDAQ:CBLL) - Defense World
Head-To-Head Survey: CeriBell (NASDAQ:CBLL) and ADM Tronics Unlimited (OTCMKTS:ADMT) - Defense World
Analysts Set CeriBell (NASDAQ:CBLL) PT at $32.50 - Defense World
Ceribell Earns FedRAMP High Authorization for Its Point-of-Care EEG - Medical Product Outsourcing
41,900 Shares in CeriBell (NASDAQ:CBLL) Acquired by Renaissance Technologies LLC - Defense World
Ceribell to Participate in the Bank of America Securities 2025 Health Care Conference - The Manila Times
CeriBell, Inc. to Present at Bank of America Securities 2025 Health Care Conference on May 14, 2025 - Nasdaq
CeriBell Gets FedRAMP High Authorization for EEG System - marketscreener.com
Ceribell Says EEG System Receives FedRAMP High Authorization - marketscreener.com
Ceribell Receives FedRAMP® High Authorization, Expanding Approval for Its AI-Powered Point-of-Care EEG Across Federal Healthcare Systems - The Manila Times
Ceribell Receives FedRAMP® High Authorization, Expanding - GlobeNewswire
Ceribell announces EEG system received full RedRAMP High authorization - TipRanks
JPMorgan Chase & Co. Takes $880,000 Position in CeriBell (NASDAQ:CBLL) - Defense World
Geode Capital Management LLC Makes New $6.65 Million Investment in CeriBell (NASDAQ:CBLL) - Defense World
Ceribell to Report First Quarter 2025 Financial Results on May 8, 2025 - The Manila Times
CeriBell, Inc. to Release Q1 2025 Financial Results and Host Conference Call on May 8, 2025 - Nasdaq
CBLL Stock Sees Surge of Approximately 3.50% in Last Five Days - knoxdaily.com
Ceribell Inc (CBLL) stock analysis: A comprehensive overview - uspostnews.com
CeriBell (NASDAQ:CBLL) Trading Down 2.9% on Insider Selling - Defense World
Ceribell's Retail Popularity Surges After Small-Cap Medtech Firm Assures No Tariff Impact Until Q4 - MSN
Alliancebernstein L.P. Invests $532,000 in CeriBell (NASDAQ:CBLL) - Defense World
Ceribell wins FDA nod for algorithm to detect pediatric seizures - MedTech Dive
Ceribell, Inc.: Promising Growth Trajectory and Strong Market Potential Reinforce Buy Rating - TipRanks
Vanguard Group Inc. Takes $18.02 Million Position in CeriBell (NASDAQ:CBLL) - Defense World
CBLL Stock Falls Despite FDA Clearance for Pediatric Clarity Algorithm - MSN
FDA Clears Ceribell’s Clarity™ Algorithm for Pediatric Patients, Making Ceribell the First and Only FDA-Cleared AI Technology for Detection of Electrographic Seizures in Patients Ages 1 Year and Older - markets.businessinsider.com
Ceribell announces FDA grants clearance for next-gen Ceribell Clarity algorithm - TipRanks
CeriBell Says FDA Clears Electrographic Seizure Detection Algorithm - marketscreener.com
FDA Clears Ceribell’s Clarity™ Algorithm for Pediatric - GlobeNewswire
Groundbreaking FDA Approval: Ceribell's AI Now Detects Seizures in Children Within Minutes - Stock Titan
Corebridge Financial Inc. Buys Shares of 6,122 CeriBell (NASDAQ:CBLL) - Defense World
Norges Bank Takes Position in CeriBell (NASDAQ:CBLL) - Defense World
CeriBell (NASDAQ:CBLL) Shares Gap Up – Still a Buy? - Defense World
Ceribell Reports Fourth Quarter and Full Year 2024 Financial Results - ADVFN
Ceribell braces for tariff impact on margins By Investing.com - Investing.com Canada
CeriBell's Stock Climbs As Tariff Relief Extends To 2025 - Finimize
Sector Update: Health Care - TradingView
CeriBell Shares Jump After Claiming Inventory in US Provides Buffer From Tariffs Until Q4 - MarketScreener
William Blair maintains Ceribell Outperform amid tariff concerns By Investing.com - Investing.com Canada
Canaccord maintains Ceribell stock buy rating, $33 target By Investing.com - Investing.com South Africa
William Blair maintains Ceribell Outperform amid tariff concerns - Investing.com Australia
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Ceribell Inc Azioni (CBLL) Dati Finanziari
Non sono disponibili dati finanziari per Ceribell Inc (CBLL). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
11.62%
0.20%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):